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Macrophages are a major target for human immunodeficiency virus type 1 (HIV-1) infection. However, macrophages are largely heterogeneous and may exhibit differences in
permissiveness to HIV-1 infection. This study highlights the interplay of macrophage
heterogeneity in HIV-1 pathogenesis. We show that monocyte-derived macrophages
(MDMs) could be divided into two distinct subsets: CD14+Siglec-1hiCD4+ (non-adherent MDM) and CD14+Siglec-1LoCD4− (adherent MDM). The CD14+Siglec-1hiCD4+MDM
subset represented the smaller proportion in the macrophage pool, and varied among
different donors. Fractionation and subsequent exposure of the two MDM subsets to
HIV-1 revealed opposite outcomes in terms of HIV-1 capture and infection. Although
the CD14+Siglec-1hiCD4+MDM captured significantly more HIV-1, infection was
significantly higher in the CD14+Siglec-1LoCD4−MDM subset. Thus, CD14+Siglec1hiCD4+MDM were less permissive to infection. Depletion of CD14+Siglec-1hiCD4+MDM
or a decrease in their percentage, resulted in increased infection of MDM, suggestive
of a capacity of these cells to capture and sequester HIV-1 in an environment that
hinders its infectivity. Increased expression of innate restriction factors and cytokine
genes were observed in the non-adherent CD14+Siglec-1hiCD4+MDM, both before
and after HIV-1 infection, compared to the adherent CD14+Siglec-1LoCD4−MDM.
We speculate that the differential expression of gene expression profiles in the two
macrophage subsets may provide an explanation for the differences observed in HIV-1
infectivity.
Keywords: monocyte-derived macrophages, human immunodeficiency virus type 1, Siglec-1, CD4, RNA-Seq,
restriction factors
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INTRODUCTION

and CD14+Siglec-1LoCD4−CD163−MDM. We characterized their
permissiveness to HIV-1 infection and their gene expression profiles in response to HIV-1. Our data revealed distinct differences
in HIV-1 infectivity and anti-HIV-1 gene expression between the
two-macrophage subsets. These results could have implications
in the role of macrophages in HIV-1 pathogenesis.

Macrophages are important targets of human immunodeficiency virus type 1 (HIV-1) infection (1–4) and may represent
specialized viral reservoirs, with the ability to store HIV-1 particles in intracellular compartments (5, 6). It has been reported
that infectious HIV-1 within macrophages are protected from
neutralizing antibodies (7), further complicating HIV-1 eradication. Due to their dissemination over different tissues and their
capacity to infiltrate virtually all organs including the brain,
macrophages could likely contribute to the spread of HIV-1 and
HIV-related pathologies, including immune dysfunction, persistent hyperimmune activation, and the onset of opportunistic
infections (4, 8, 9).
In humans, macrophages arise from circulating or resident
monocytes which are largely present in the blood, spleen and
bone marrow. Circulating monocytes exhibit heterogeneity and
are classified into classical monocytes, intermediate, and nonclassical monocytes. Although earlier reports defined circulating monocytes as the precursors of tissue macrophages, recent
studies have shown that tissue macrophages with self-renewal
properties could arise from yolk sac, liver, and bone-marrow
independent of monocyte precursors (10–12). Therefore, circulating monocytes represent only one source of tissue resident
macrophages. The necessity of the circulating monocytes to
repopulate macrophages in certain tissues versus the ability
of macrophages to self renew in other tissues independent of
circulating monocytes (13), highlights the complexity of tissue
resident macrophage populations.
In human lungs, macrophage heterogeneity in the bronchoalveolar space is reflected by the presence of small and large alveolar
macrophages, with small alveolar macrophages being more
susceptible to HIV-1 infection than large alveolar macrophages
(14). In the lungs of rhesus macaques, macrophage heterogeneity
is exemplified by the presence of multiple macrophage popu
lations including alveolar and interstitial macrophages (15),
with interstitial macrophages being more permissive to simian
immunodeficiency virus than alveolar macrophages (16).
Until recently, CD4 and chemokine receptors were the major
cellular molecules associated with HIV-1 infection. However,
recent studies have revealed the involvement of sialic acid-binding immunoglobulin-like lectin-1 (Siglec-1, CD169) in HIV-1
infection of myeloid cells. Siglec-1 is an interferon-inducible
member of the I-type lectin receptor family found on the surface of dendritic cells and macrophages. In vivo, expression of
Siglec-1 on myeloid cells is upregulated by immune activation,
and these cells have been shown to accumulate in the CD4+
T cells-enriched lymphocyte tissues (17). Siglec-1 on dendritic
cells captures HIV-1 by binding to sialyllactose-containing
gangliosides exposed on HIV-1 membranes (18, 19). Siglec-1
also facilitates HIV-1 infection of macrophages via its interaction with sialic acid on gp120 (20, 21). It was recently reported
that Siglec-1 mediated the accumulation of HIV-1 into viruscontaining compartments of macrophages and also mediated the
transinfection of autologous T cells (22).
In this study, using an in vitro infection system, we identified two
distinct macrophage subsets, CD14+Siglec-1hiCD4+CD163+MDM
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MATERIALS AND METHODS
Antibodies

The following human monoclonal antibodies (mAbs) antiCD11b PE (clone ICRF44), CD11b FITC (clone ICRF44), CD14
APC (clone M5E2), CD14 PerCP (clone MoP9), CD163 FITC
(clone GHI/61), CD4 PE (clone RPA-T4), CD3 PerCP (clone
SK7), CD195 FITC (2D7/CCR5), and 7-amino actinomycin D
(7-AAD) were obtained from BD Pharmingen. Anti-CD169 APC
(clone 7-239) was obtained from BioLegend. Anti-p24-FITC and
anti-p24-RD1 were purchased from Beckman Coulter.

Media and Reagents

Media components and reagents were obtained as follows:
RPMI-1640 (BioWhittaker), l-glutamine and penicillin/streptomycin (Quality Biologicals Inc.), Accutase (eBiosciences),
recombinant human M-CSF (PeproTech), polybrene, bovine
serum albumin (BSA), PKH-67, and PKH-26 (Sigma-Aldrich),
and fetal bovine serum (Gemini Bio Products). Fixation and
permeabilization buffers (Reagents A and B) were from Caltag.
Monocyte media consisted of RPMI-1640 supplemented with
10% heat-inactivated FBS, 1% l-glutamine, and 1% penicillin/
streptomycin. M-CSF media (monocyte media supplemented
with 50 ng/ml M-CSF) was used for differentiating the monocytes into macrophages. For infecting the macrophages, M-CSF
media containing 2 µg/ml polybrene (Infection media) was used.

Virus Purification

HIV-1 primary subtype B viruses (US-1, BaL, and JRFL) were
grown in peripheral blood mononuclear cells (PBMCs) from
stocks obtained from Dr. Victoria Polonis (USMHRP). The
primary viruses were purified as previously described (23).
Infectivity and p24 concentration were determined before and
after purification to ensure that infectivity was not lost during the
purification procedure.

Enrichment and In Vitro Culture of
Monocytes

Peripheral blood mononuclear cells from healthy HIV-1
seronegative donors were isolated by Ficoll density gradient centrifugation under an internal review board-approved protocol,
RV229/WRAIR number 1386. Monocytes were enriched from
the PBMCs by plastic adherence in 24-well plates (Corning),
and differentiated into monocyte-derived macrophages (MDM)
in 1 ml M-CSF media, as previously described (21). MDM
were used on day 5 postculture for flow cytometry. For HIV-1
infection, polybrene (2 µg/ml) was added to the MDM cultures
during the last 30 min of the in vitro culture, before subsequent
exposure to HIV-1.
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Fractionation of MDM

the MDM to the plate, rendering it difficult to separate the nonadherent MDM from their adherent counterparts. Equal numbers
(3–5 × 105) of fractionated adherent MDM (Siglec-1LoCD4−) and
non-adherent MDM (Siglec-1hiCD4+) were each resuspended in
100 µl of infection media, transferred to 5 ml polystyrene tubes
(Falcon), and incubated at 37°C/5% CO2 for 30 min followed by
the addition of purified HIV-1 (1–5 ng p24) for an additional 3 h.
Unadsorbed virus was removed following multiple washes (5×)
with 1× PBS. Cells were lysed for determination of virus capture,
and the lysates were evaluated for the presence of gag RNA by
qRT-PCR. For evaluation of virus replication, the cell pellets were
resuspended in 1 ml of infection media, transferred into 24-well
flat-bottom plates, and incubated at 37°C/5% CO2. Culture
supernatants and cells were harvested on day 4 postinfection. The
presence of p24, indicative of HIV-1 infection, was determined in
the two MDM subsets by flow cytomery (intracellular p24), and
in the culture supernatants by ELISA (extracellular p24).

M-CSF-derived MDM cultures comprised two cell fractions—
adherent and non-adherent. The non-adherent MDM were
isolated from their adherent counterparts by repeated gentle
washes with monocyte media. The non-adherent MDM were
gently aspirated, and collected in 50 ml tubes. Accutase (500 µl)
was added to the remaining adherent MDM, and the cultures
were incubated at 37°C/5% CO2 for 20 min, to detach the cells
(24). The detached MDM were transferred into 50 ml tubes, and
washed with monocyte media. The viability of both adherent and
non-adherent MDM was ≥ 98% as determined by trypan blue
exclusion.

Detection of Cell Surface Molecules

Unfractionated or fractionated MDM (adherent and nonadherent) were washed in cold FACS buffer (PBS-containing
0.5% BSA) and blocked in FACS buffer containing 10% normal
goat serum. The cells were incubated for 20 min on ice with a
cocktail containing 5–10 µg of the specific mAb or their corresponding isotype mAbs as controls. Cells were washed in cold
FACS buffer and fixed in PBS-containing 2% paraformaldehyde.
Cells were acquired on a FACSCalibur (BD Biosciences, San Jose,
CA, USA). Data analyses were performed on the gated 7-AAD
negative MDM (CD14+) using FlowJo 8.8.6 software (TreeStar
Inc., Ashland, OR, USA).

HIV-1 Infection of Unfractionated and
Siglec-1hiCD4+ Depleted MDM

Replicate wells of unfractionated MDM and Siglec-1hiCD4+
(non-adherent)-depleted MDM were incubated in 1 ml of
Infection media for 30 min at 37°C/5% CO2. Purified HIV-1
(1–5 ng p24) was added to each well and the cultures were
incubated at 37°C/5% CO2. Cultures were harvested on day 4
postinfection and analyzed for the presence of intracellular p24
by flow cytometry.

Cell Sorting of MDM

Unfractionated MDM were harvested, pooled, and incubated
with a mAb cocktail (CD14 FITC, CD4 PE, CD3 PerCP,
Siglec-1 APC) on ice for 20 min. Cells were washed, and the
pellet was resuspended in cold FACS buffer. An aliquot of the
stained cells was acquired on a FACSCalibur before cell sorting. The remaining stained cells were sorted on an LSRII (BD
Biosciences, San Jose, CA, USA). Data analyses were performed
on the gated CD14+MDM, using FlowJo 8.8.6 software (TreeStar
Inc., Ashland, OR, USA). The following gating strategy was
used: Singlets were identified and gated by their forward scatter
height (FSC-H) and area (FSC-A) characteristics. The live cells
within the gated singlets were identified and gated. MDM in
the gated live population were identified by their CD14+CD3−
characteristics. The defined CD14+CD3− cells were gated and
further defined into a Siglec-1 versus CD4 dot plot. The cells
segregated into two populations, Siglec-1hiCD4+MDM and
Siglec-1LoCD4−MDM, which were subsequently collected into
two separate tubes (Figure S1 in Supplementary Material).

Coculture Assays

Unfractionated MDM were exposed to HIV-1 or media for 1 h.
Cells were fractionated into non-adherent (Siglec-1hiCD4+) and
adherent (Siglec-1LoCD4−) MDM, and washed to remove unadsorbed virus. Siglec-1hiCD4+MDM were pooled and counted.
Duplicate wells of Siglec-1LoCD4−MDM were counted as an indicator for the number of Siglec-1LoCD4−MDM in each well. Equal
numbers of HIV-1-exposed non-adherent Siglec-1hiCD4+MDM
were cocultured with HIV-1 naive PKH-67-labeled adherent
Siglec-1LoCD4−MDM. HIV-1 naive Siglec-1hiCD4+MDM were
also cocultured with HIV-1 exposed PKH-67-labeled Siglec1LoCD4−MDM. Independent cultures of HIV-1-exposed nonadherent Siglec-1hiCD4+MDM and HIV-1-exposed PKH-26labeled adherent Siglec-1LoCD4−MDM were setup in parallel. The
cultures were incubated for 2–3 days at 37°C/5% CO2, harvested,
and analyzed for HIV-1 infectivity by flow cytometry.

qRT-PCR

HIV-1 Capture and Replication in
Fractionated MDM

RNA was extracted from HIV-1-infected MDM subsets and
the presence of gag RNA was determined by qRT-PCR as
previously described (21, 25). Briefly, RNA was extracted from
MDM using the RNeasy Mini Kit and Qiashredder (Qiagen)
and the RNA was eluted in RNase free water. The qRT-PCR
reactions were performed using the TaqMan RNA-to-Ct master mix (Applied Biosystems) and Viia7 (Applied Biosystems).
Reactions (50 µl) were performed in the presence of the
master mix, 0.2 µM each of Gag forward and reverse primers,

In our previous study (21), the MDM were infected by spinoculation. In our current study, HIV-1 was gently mixed with the
MDM cultures, with minimal perturbation, and incubated for the
specified time-periods. The rationale for this modification was
necessitated by our goal to maintain the MDM as non-adherent
and adherent subsets. Although higher infectivity is achieved
with spinoculation, this mechanical procedure would affix all
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with p-values ≤0.05 and log 2 fold-changes greater than an
absolute value of 2.
For each contrast extracted with Limma, global perturbations
in known Gene Ontology (GO) terms and KEGG pathways
were detected using the R/Bioconductor packages GAGE to
test for changes in expression of the reported log 2 fold-changes
reported by Limma in each term versus the background log 2
fold-changes of all genes found outside the respective term. The
R/Bioconductor package heatmap3 was used to display heatmaps
of genes across samples for each GO terms with a p-value ≤0.05.
The R/Bioconductor package Pathview was then used to generate annotated pathway maps on perturbed KEGG signaling and
metabolism pathways. The logFC values reported in column B
in Table S1 in Supplementary Material are the fold-changes as
reported by Limma’s weighted generalized linear model likelihood ratio test for the contrast of adherent and non-adherent
MDM’s (26–29).

Gag probe and 1× human GAPDH VIC-TAMRA (Applied
Biosystems). Cycling parameters were 48°C for 20 min, 95°C
for 10 min; then 45 cycles at 95°C for 15 s, and 59°C for 1 min.
Delta Ct values were calculated to normalize the HIV-1 gag
RNA signal as a function of the GAPDH/cellular RNA signal.

Detection of Intracellular and Extracellular
HIV-1 p24 Antigen

Staining for detection of intracellular p24 in HIV-1 infected
MDM was carried out as previously described (23). Data analyses were performed using FlowJo 8.8.6 software (TreeStar Inc.,
Ashland, OR, USA). The concentration of extracellular HIV gag
p24 in the culture supernatants was determined using a HIV-1
p24 Antigen Capture Assay kit (ABL).

RNA-Seq Analysis of Cellular Genes

RNA was isolated from uninfected and HIV-1 infected MDM
using the RNeasy Mini Kit (Qiagen) and the concentration
was determined using Nanodrop 2000 (Thermo Scientific).
The eluted RNA had a 260/280 of greater than 1.8. The samples
were analyzed for quality on an Agilent BioAnalyzer and all
samples had a RNA Integrity Number (RIN) value of greater
than 9.5. Samples were then prepared for sequencing with the
Clontech SMARTer system, indexed, pooled, and sequenced as
a single 1 × 50 bp lane on an Illumina HiSeq 3000. RNA-seq
reads were demultiplexed and aligned to the Ensembl release
76 top-level assembly with STAR version 2.0.4b. Gene counts
were derived from the number of uniquely aligned unambiguous reads by Subread:featureCount version 1.4.5. Sequencing
performance was assessed for total number of aligned reads,
total number of uniquely aligned reads, and genes detected.
The ribosomal fraction (Figure S2 in Supplementary Material),
known junction saturation (Figure S3 in Supplementary
Material), and read distribution over known gene models
(Figure S4 in Supplementary Material) were quantified with
RSeQC version 2.3.
All gene counts were then imported into the R/Bioconductor
package EdgeR and TMM normalization size factors were
calculated to adjust for samples for differences in library size.
Ribosomal genes and genes not expressed in any sample greater
than one count-per-million were excluded from further analysis. The TMM size factors and the matrix of counts were then
imported into R/Bioconductor package Limma. Performance of
the samples was assessed with a Spearman correlation matrix.
Sample outliers with confounding levels of variance found
in the correlation plot were removed from further analysis
(Figure S5 in Supplementary Material). Weighted likelihoods
based on the observed mean-variance relationship of every
gene and sample were then calculated for all samples with the
voom WithQualityWeights function and gene performance was
assessed with plots of residual standard deviation of every gene to
their average log-count with a robustly fitted trend line of the
residuals (Figure S6 in Supplementary Material). Generalized
linear models were then created to test for gene level differential
expression and the results were filtered for only those genes
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Accession Number

The accession number for the raw and processed files for the
RNA-seq reported in this article is GEO: GSE103666.

Statistical Analysis

Differences were compared using the Mann-Whitney test
(Graphpad Prism 5, Version 5.0c). A p-value of ≤0.05 was considered statistically significant. Statistical analyses for the RNASeq data were performed as mentioned above in the RNA-Seq
analysis of cellular genes.

RESULTS
M-CSF-Derived MDM Comprised Two
Subsets-Siglec-1hiCD4+MDM and
Siglec-1LoCD4−MDM

We have previously demonstrated that blocking Siglec-1 receptor on MDM resulted in 90–95% inhibition of HIV-1 infection,
whereas blocking CD4 receptor inhibited infection in 50–55%
of MDM (21). Thus, we investigated the possible existence of
subsets of MDM that coexpressed varying amounts of Siglec-1
and CD4. Both adherent and non-adherent cells were evident
in the M-CSF-derived MDM cultures. Flow cytometric analysis
of the combined adherent and non-adherent fractions showed
that M-CSF-derived MDM, irrespective of the donor, segregated
into two distinct subsets: Siglec-1hiCD4+ and Siglec-1LoCD4−
(Figure 1A). Two notable observations were made. First, within
the MDM cultures in all nine donors, Siglec-1hiCD4+MDM
comprised a lower proportion of cells (0.6–22.7%) compared
to Siglec-1LoCD4−MDM (62.8–94.9%). Second, the proportion
of Siglec-1hiCD4+MDM varied among donors (Table 1). Both
MDM subsets expressed similar frequencies of CD14, and were
negative for CD3, implying the absence of T-cell contamination
(Figure 1B).
Since the main goal of this study was to individually evaluate
the two different MDM subsets for HIV-1 infection, we utilized
two different methods (cell sorting and cell fractionation) to
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FIGURE 1 | Monocyte-derived macrophage (MDM) segregate into two distinct subsets: Non-adherent Siglec-1hiCD4+MDM and adherent Siglec-1LoCD4−MDM.
Triplicate wells of primary human monocytes from nine human immunodeficiency virus (HIV)-seronegative donors (#048, #130, #170, #008, #002, #202, #132,
#124, and #040) were differentiated into MDM following in vitro culture in M-CSF media for 5 days. Cultures were harvested, stained, and analyzed by flow
cytometry. (A) Plots show percentage of Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM within the gated CD14+ cells. A representative plot of one of the two
independent experiments is shown. (B) Plots show that gated CD14+ cells are not contaminated with CD3+ T cells. (C,D) In vitro cultures of M-CSF-derived
MDM contain adherent and non-adherent MDM. (C) Adherent and non-adherent MDM were pooled, stained, and the gated CD14+ cells were sorted into
Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM. (D) Non-adherent MDM were separated from adherent MDM following repeated washing with media. Adherent
MDM were detached with Accutase. Both fractions were washed, stained, and the gated CD14+ cells were analyzed separately for the expression of Siglec-1 and
CD4. Plots show that non-adherent fraction represented the Siglec-1hiCD4+MDM subset, whereas the adherent fraction comprised the Siglec-1LoCD4−MDM subset.
(E) Histograms show the expression of CCR5 and CD163 on the gated Siglec-1LoCD4−MDM (blue) and Siglec-1hiCD4+MDM (red) subsets. Values in the histograms
denote the mean fluorescent intensity (MFI) of the specific receptors for each of the subsets. Each experiment was done twice in triplicate and the data from one of
the two experiments are shown.

separate the two MDM subsets. For cell sorting, the MDM were
stained with a mAb cocktail and subjected to sorting by flow
cytometry (Figure 1C). MDM were sorted into the two subsets
(Siglec-1hiCD4+ and Siglec-1LoCD4−) with 89–90% purity. The
second method employed was cell fractionation (Figure 1D).
The fractionation procedure was based on the differential
adherence characteristics of the two different subsets of MDM.
Although, both procedures (Figures 1C,D) yielded highly
enriched and pure subsets, the fractionation procedure was
simple, inexpensive, gentle, fast, and circumvented the possible
effects of antibody exposure and subsequent mechanical cell

TABLE 1 | Mean fluorescence intensity (MFI) of Siglec-1 for Siglec-1hiCD4+MDM
and Siglec-1LoCD4−MDM from various donors.
Donor
#048
#130
#170
#008
#002
#202
#132
#124
#040

Siglec-1hiCD4+MDM

Siglec-1LoCD4−MDM

46.7
188.0
142.0
88.3
80.5
167.0
175.0
143.0
66.5

29.1
29.5
66.3
19.0
66.3
14.6
41.6
20.4
17.1
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subset of Siglec-1LoCD4−CD163−MDM (adherent), with a
relatively lower expression of Siglec-1, and devoid of CD4 and
CD163.

sorting. With all donors, routine flow cytometric analyses of the
fractionated MDM subsets consistently revealed that the nonadherent MDM represented the Siglec-1hiCD4+MDM, whereas
the adherent MDM comprised the Siglec-1LoCD4−MDM (data
not shown). Therefore, we utilized the fractionation procedure
for the experiments described in this study. Evaluation of HIV-1
coreceptor (CCR5) revealed that the expression of CCR5 was
similar on both subsets, whereas the scavenger receptor (CD163)
was only coexpressed on Siglec-1hiCD4+MDM (Figure 1E).
These data reveal the existence of two subsets of M-CSFderived MDM; a small subset of Siglec-1hiCD4+CD163+MDM
(non-adherent), with a relatively high expression of molecules
that are associated with HIV-1 infection, and a more prominent

Siglec-1hiCD4+MDM Dampens the
Degree of HIV-1 Infectivity

The presence of relatively high levels of molecules that are
associated with HIV-1 infection on the M-CSF-derived MDM
subset led us to hypothesize that the non-adherent Siglec1hiCD4+MDM would be highly permissive to HIV-1 infection.
To address this hypothesis, we evaluated the degree of HIV-1
infection in unfractionated and Siglec-1hiCD4+ depleted MDM.
We utilized the fractionation procedure mentioned above in

FIGURE 2 | Presence of Siglec-1hiCD4+MDM dampens the degree of human immunodeficiency virus type 1 (HIV-1) infection. Monocytes from three donors were
differentiated into monocyte-derived macrophage (MDM) with M-CSF media. (A) Panels show plots of unfractionated MDM and their Siglec-1hiCD4+MDM-depleted
counterparts. (B) Unfractionated MDM and Siglec-1hiCD4+MDM-depleted cultures were infected with purified HIV-1 (BaL, JRFL, or US-1). Cells were harvested
on day 3 postinfection, stained, and analyzed by flow cytometry. Panels show plots of HIV-1 infection in the unfractionated MDM cultures and in their Siglec1hiCD4+MDM-depleted counterparts. Values in the upper right quadrant(s) represent the percentage of infected MDM. Data represent one of the triplicate
wells from one of two independent experiments. (C) Bar graph is derived from the experiment performed in Figure 2B and includes the data from the
triplicate wells of two independent experiments and shows the% p24+MDM (mean ± SD) in unfractionated MDM (filled bars) or in the
Siglec-1hiCD4+MDM-depleted MDM (open bars) following infection with HIV-1. Significance is indicated by *p ≤ 0.05.
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three donors (#170, #130, and #002), to remove non-adherent
Siglec-1hiCD4+MDM from the adherent MDM population.
The efficiency of the fractionation procedure to deplete Siglec1hiCD4+MDM from the cultures was confirmed by flow cytometry (Figure 2A). Unfractionated MDM and Siglec-1hiCD4+
depleted MDM from multiple donors were infected with three
different HIV-1 subtype B purified viruses (BaL, JRFL, and US-1).
The degree of infectivity was variable among the donors with
each of the viruses. Surprisingly, with all the viruses and in all
the donors, HIV-1 infection was consistently and significantly
higher (p ≤ 0.05) in Siglec-1hiCD4+MDM-depleted cultures
compared to unfractionated MDM cultures, (Figures 2B,C).
Our data demonstrate that in an in vitro infection set-up, Siglec1hiCD4+MDM dampened the effect on the degree of HIV-1
infection. This suggests that in vitro, the outcome of HIV-1 infection may be related to the percentage of Siglec-1hiCD4+MDM
in the well.

This is indicative of macrophage plasticity, and suggests that
Siglec-1LoCD4−MDM are the precursors of Siglec-1hiCD4+MDM.
Notably, HIV-1 infection was mainly evidenced in the gated
Siglec-1LoCD4−MDM (Figure 3G), but not in the Siglec1hiCD4+MDM (Figure 3H).

Siglec-1hiCD4+MDM Although Poorly
Permissive Do Transfer HIV-1 to Siglec-1Lo
CD4−MDM

Despite increased HIV-1 capture (Figure 3A), virus replication was restricted in Siglec-1hiCD4+MDM (Figures 3B–D).
It may be possible that Siglec-1hiCD4+MDM only captured
and sequestered HIV-1. However, it is equally plausible that
Siglec-1hiCD4+MDM facilitated transfer of captured virions to
other cells. To evaluate this, we exposed unfractionated M-CSFderived MDM to BaL for 1 h. The HIV-1-exposed MDM were
fractionated into non-adherent and adherent populations.
Phenotypic analysis of aliquots of the non-adherent and adherent fractions confirmed that they were Siglec-1hiCD4+MDM and
Siglec-1LoCD4−MDM, respectively (data not shown). The HIV1-exposed Siglec-1LoCD4−MDM were labeled with PKH-26,
a cell membrane-labeling dye. The HIV-1-exposed MDM subsets
were cultured independently, and served as infection controls
(Figure 4A,B). Although HIV-1 infection was detected in both
subsets, it was higher in the Siglec-1LoCD4−MDM compared
to the Siglec-1hiCD4+MDM in all three donors (Figure 4A,B).
These data further highlighted that the Siglec-1hiCD4+MDM
subset were less permissive to HIV-1 infection and are consistent
with the results shown in Figures 3B–D.
To evaluate whether the HIV-1-exposed MDM subsets
exhibited differences in their ability to transfer HIV-1, Siglec1hiCD4+MDM from the three donors that were exposed to BaL
were cocultured for 3 days with uninfected Siglec-1LoCD4−MDM
that were labeled with PKH-67 to distinguish them from Siglec1hiCD4+MDM or from Siglec-1hiCD4+MDM that may have
down-regulated Siglec-1 and CD4 during infection. As shown
in Figure 4C, HIV-1 infection (3.85, 10.3, and 8.66%, respectively) was evident in the PKH-67-labeled Siglec-1LoCD4−MDM
in all three donors. This indicated that the HIV-exposed
Siglec-1hiCD4+MDM transferred virus to the uninfected PKH67-labeled Siglec-1LoCD4−MDM.
In parallel, uninfected Siglec-1hiCD4+MDM were cocultured
with HIV-exposed Siglec-1LoCD4−MDM that were labeled
with PKH-26 (Figure 4D). The coculture resulted in decreased
infection (Figures 4B,D), suggestive of an inherent ability of
Siglec-1hiCD4+MDM to restrict HIV-1 infection. These results are
consistent with the data shown in Figure 2. The HIV-1-infected
cells were largely restricted within the HIV-exposed PKH26-labeled Siglec-1LoCD4−MDM.

Siglec-1hiCD4+MDM Are Efficient at HIV-1
Capture but Less Permissive to Infection

We sought to further investigate the interaction of the two
MDM subsets with HIV-1. In this regard, we evaluated if the
two subsets exhibited differences in their ability to capture
virus, and/or support infection. Equal numbers of fractionated Siglec-1LoCD4−MDM and Siglec-1hiCD4+MDM from
different donors were exposed to three different subtype B
HIV-1 (BaL, US-1, JRFL). First, we evaluated HIV-1 capture
by the two subsets (Figure 3A). This was determined by the
presence of gag RNA using qRT-PCR. The cells were harvested
at 3 h postinfection. RNA was isolated from cell lysates and
qRT-PCR was performed. The data are plotted as ΔCt values.
A low ΔCt value represents a higher amount of viral RNA.
As shown in Figure 3A, HIV-1 capture of all three viruses
was significantly higher in the Siglec-1hiCD4+MDM (lower
Ct value), compared to Siglec-1LoCD4−MDM (higher Ct
value) in all three donors. Next, we evaluated HIV-1 infection at day 4 postinfection. HIV-1 infection was determined
by the presence of intracellular p24 using flow cytometry
(Figures 3B,C), as well as the presence of extracellular p24
in the supernatants using ELISA (Figure 3D). Interestingly,
in all the donors and with all three viruses, the percentage
of p24 positive MDM was significantly higher in the Siglec1LoCD4−MDM compared to the Siglec-1hiCD4+MDM subset
(Figures 3B,C). Parallel determination of extracellular p24
in the culture supernatants also revealed significantly higher
levels in Siglec-1LoCD4−MDM cultures, than in the Siglec1hiCD4+MDM cultures (Figure 3D). Collectively, these results
suggest that although Siglec-1LoCD4−MDM are less efficient
at HIV-1 capture than Siglec-1hiCD4+MDM, they are more
permissive to HIV-1 infection.
Although the fractionated Siglec-1LoCD4−MDM were initially
devoid of Siglec-1hiCD4+MDM and were cultured as a relatively
pure subset, we detected the presence of Siglec-1hiCD4+MDM
at day 4 postinfection in the uninfected controls (Figure 3E), as
well as in the infected Siglec-1LoCD4−MDM cultures (Figure 3F).
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Differential Expression of HIV-1 Restriction
Factors and Cytokine Genes in Siglec-1hi
CD4+MDM and Siglec-1LoCD4−MDM

The expression of cellular restriction factors and cytokine
genes that affect HIV-1 infection in macrophages have been
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FIGURE 3 | Human immunodeficiency virus type 1 (HIV-1) infection is lower in Siglec-1hiCD4+MDM despite higher virus capture. Equal numbers (3 × 105 cells) of
Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM from three HIV-seronegative donors (#130, #170, #132) were incubated with HIV-1 (BaL, JRFL, or US-1) for 3 h at
37°C/5% CO2. (A) Cell lysates were subjected to qRT-PCR to detect gag RNA transcripts, indicative of virus capture. Uninfected cell lysates were negative for gag
RNA transcripts (not shown). Bar graphs show the delta Ct (normalized) gag RNA in Siglec-1hiCD4+MDM (red bars) and Siglec-1LoCD4−MDM (blue bars) for each
donor and with each virus. Data are representative of three independent experiments and show the mean values (***p ≤ 0.001). (B,C) Siglec-1hiCD4+MDM and
Siglec-1LoCD4−MDM were infected with HIV-1. Cultures were harvested on day 4 postinfection, washed, stained, and analyzed for the presence of intracellular p24
by flow cytometry. (B) Panels show plots of HIV-1 infection in gated Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM from a representative donor. (C) Bar graph shows %
p24+MDM of triplicate wells of three independent experiments (mean ± SD; *p ≤ 0.05) in Siglec-1LoCD4−MDM (blue bars) and in the Siglec-1hiCD4+MDM (red bars)
following infection with US-1, BaL, or JRFL. (D) Supernatants from cultures of HIV-1-infected Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM were harvested on day
4 postinfection, and analyzed by ELISA for the presence of extracellular p24. Bar graphs show the p24 concentration of triplicate wells of two independent
experiments (mean ± SD; *p ≤ 0.05) in the supernatants of HIV-1-infected Siglec-1LoCD4−MDM (blue bars) and Siglec-1hiCD4+MDM (red bars) for each donor and
with each virus. (E,F) Siglec-1LoCD4−MDM (#130) were left uninfected, or (F) were infected with HIV-1. Plots show the presence of Siglec-1hiCD4+MDM both in (E)
the uninfected Siglec-1LoCD4−MDM cultures and in (F) their HIV-1-infected Siglec-1LoCD4−MDM cultures. (G,H) The HIV-1-infected monocyte-derived macrophage
(MDM) described in (F) were analyzed for localization of HIV-1 on the basis of their Siglec-1LoCD4−MDM versus Siglec-1hiCD4+MDM phenotype. Panels show that
the presence of HIV-1 infection only in (G) gated Siglec-1LoCD4−MDM and not in the (H) gated Siglec-1hiCD4+MDM. Values in the upper right quadrant(s) represent
the percentage of infected MDM. A representative plot of three independent experiments is shown.

RNA-Seq (Figure 5; Table S1 in Supplementary Material). One
of the donors, #130 was inconsistent in the data compared to
the other two donors (Figure S5 in Supplementary Material) and
therefore the data from #130 was removed. Known genes for
cellular restriction factors and cytokines that were considered
significantly different in the two subsets, Siglec-1LoCD4−MDM
and Siglec-1hiCD4+MDM were chosen. Of these, the 23 genes

previously described (30–39). To gain more insight into the
possible reasons for the differential permissivity to HIV-1
infection observed in our study, we examined M-CSF-derived
MDM from three donors that were fractionated into Siglec1LoCD4−MDM and Siglec-1hiCD4+MDM, in the absence or
presence of HIV-1 for 3 h. The expression levels of cellular
restriction factors and cytokine-related genes were analyzed by
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FIGURE 4 | Siglec-1hiCD4+MDM transfer human immunodeficiency virus type 1 (HIV-1) to Siglec-1LoCD4−MDM. (A) M-CSF-derived monocyte-derived macrophage
(MDM) from three donors were incubated with media or with HIV-1 (BaL) for 1 h at 37°C/5% CO2. Cells were washed and fractionated into Siglec-1hiCD4+MDM
and Siglec-1LoCD4−MDM. The infected Siglec-1LoCD4−MDM were subsequently labeled with PKH-26. Both subsets were cultured at 37°C/5% CO2. (A) Plots
show the percentage of infected cells at 3 days postculture in the infected Siglec-1hiCD4+MDM and (B) the infected Siglec-1LoCD4−MDM. (C) HIV-1 exposed
Siglec-1hiCD4+MDM were cocultured with PKH-67-labeled uninfected Siglec-1LoCD4−MDM. Plots show evidence of HIV-1 infection in both the Siglec1hiCD4+MDM and the PKH-67-labeled Siglec-1LoCD4−MDM. (D) In parallel, PKH-26-labeled HIV-1-exposed Siglec-1LoCD4−MDM were cocultured with
uninfected Siglec-1hiCD4+MDM. Plots show evidence of HIV-1 infection mostly in the PKH-26-labeled Siglec-1LoCD4−MDM.

selected were within the top 7,500 differentially expressed genes.
We observed a trend of higher cellular restriction factor gene
expression including viperin (RSAD2), SLFN11, IFI16, TREX1,
APOBEC family, tetherin (BST2), TRIM5, and TRIM22 in the
non-adherent Siglec-1hiCD4+MDM compared to the adherent
Siglec-1LoCD4−MDM. This pattern of differential expression
was observed in the uninfected subsets and remained in the
HIV-1 infected Siglec-1LoCD4−MDM and Siglec-1hiCD4+MDM.
Viperin (RSAD2), TRIM22, IFI16, and APOBEC3D were all
within the top 200 differentially expressed genes. Surprisingly,
the expression of SAMHD1 (40–42), SERINC5, and SERINC3
(43, 44), was higher in the HIV-1 permissive Siglec-1LoCD4−MDM
compared to the less permissive Siglec-1hiCD4+MDM, despite
their innate antiviral properties. Cyclin-dependent kinases
(CDK1, CDK2) which phosphorylate SAMHD1 and impair its
HIV-restriction ability (45–47), showed a higher expression
in Siglec-1LoCD4−MDM compared to Siglec-1hiCD4+MDM. In
addition to restriction factors, cytokines such as IL-12 and IL-13
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also influence HIV-1 replication in MDM (32, 33, 48). Expression
of the genes for the IL-12R and IL-13 were higher in the HIV-1restrictive Siglec-1hiCD4+MDM. This subset also showed higher
gene expression for insulin growth factor-1 (IGF-1), which has
been previously demonstrated to be present in activated alveolar
macrophages and to inhibit HIV-1 replication in cultured cord
blood mononuclear cells as well as in chronically HIV-1 infected
U937 cells (30, 49). These trends in gene expression profiles show
that several factors that restrict HIV-1 infectivity were more
highly expressed in the non-adherent Siglec-1hiCD4+MDM compared to the adherent Siglec-1LoCD4−MDM and is suggestive of
the restricted HIV-1 infection that we observed.

DISCUSSION
Macrophages are important targets for HIV-1 infection (50).
In a recent study, it was shown that macrophages were capable
of sustaining HIV-1 infection in the absence of T cells (4). In
9
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FIGURE 5 | Heat map of expression of human immunodeficiency virus type 1 (HIV-1) restriction factors and cytokine genes in uninfected and HIV-1-infected
Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM. M-CSF-derived monocyte-derived macrophage (MDM) from two donors were fractionated into Siglec-1hiCD4+MDM
and Siglec-1LoCD4−MDM. The MDM subsets were incubated with media or with HIV-1 (BaL) for 3 h at 37°C/5% CO2. The expression levels of cellular restriction
factors, insulin growth factor-1 (IGF-1), IL-13, and IL-12-related genes were analyzed by RNA-Seq. Relative expression levels of HIV-1 restriction genes are shown
for uninfected and infected Siglec-1hiCD4+MDM and Siglec-1LoCD4−MDM samples with a self-clustering heatmap generated by the R/CRAN package heatmap3.
Samples and genes are clustered by their respective expression profiles and every row is rescaled to have a mean of zero and standard deviation of 0 in order to
illustrate relative expression changes across samples on a scale similar to log 2 fold-change. Blue indicates low expression, and red indicates high expression.

compartments such as the central nervous system, macrophages
are the principal targets for HIV-1 (51). HIV-1-infected tissueresident macrophages are largely resistant to the cytopathic
effects of the virus. Unlike HIV-1-infected CD4+ T cells which
are progressively depleted by mechanisms including apoptosis,
infected macrophages are largely resistant to apoptosis (52). As
a result, macrophages can harbor HIV-1 for extended periods
(53–55), making them a major factor in the establishment of
the viral reservoir (56). Macrophages are central to the innate
immune response, and may be important in the control of opportunistic infections. It is therefore conceivable that perturbation of
macrophage responses and functions as a result of HIV-1
Frontiers in Immunology | www.frontiersin.org

infection may impair innate immune control and allow for the
onset of opportunistic infections.
In the present study, MDM were used. However, macrophages
are not all derived from circulating monocytes. Indeed,
accumulating evidence suggests the presence of resident macrophages in several tissues that self-renew locally throughout
adult life, independently of circulating monocytes (10, 11,
13, 57). Nonetheless, irrespective of the donors tested in our study,
the MDM segregated into two distinct subsets; non-adherent and
adherent. The two subsets exhibited a differential expression of
cellular receptors associated with HIV-1 such as Siglec-1, CD4,
and CD163. The non-adherent MDM were Siglec-1hiCD4+ and the
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uninfected and HIV-1-infected Siglec-1hiCD4+MDM and
Siglec-1LoCD4−MDM, and compared the expression of several
well-characterized cellular factors that restrict HIV-1 infection.
The non-adherent Siglec-1hiCD4+MDM expressed higher levels
of several restriction factor genes that affect HIV-1 replication
and release of infectious virus, even prior to HIV-1 exposure.
While some genes directly inhibit HIV-1, other genes may induce
innate factors that restrict HIV-1 infection. The higher expression
of TRIM22 (37, 64), BST2 (tetherin) (65–67), APOBEC (68–70),
and SLFN11 (71–73), by non-adherent Siglec-1hiCD4+MDM
indicated that these MDM may be more restrictive to HIV-1
infection. The higher expression of the cyclin-dependent kinases
in Siglec-1LoCD4−MDM may also explain the increased HIV-1
infectivity in these MDM despite their increased SAMHD1
expression profile. In addition, IL-12R1 and IL-12R2, IL-13,
and IGF-1 genes were upregulated in the non-adherent Siglec1hiCD4+MDM. Since these genes have been reported to inhibit
viral replication, we speculate that they may contribute to the
restrictive permissivity observed with the non-adherent Siglec1hiCD4+MDM. Other methods including qPCR will be employed
to confirm these data. This differential pattern of HIV-1 restrictive genes expression was maintained postinfection.
Our study identified two macrophage subsets that interact
differentially with HIV-1. Siglec-1hiCD4+MDM, an HIV-1 res
trictive subset, captures and transfers virus to macrophages.
Siglec-1LoCD4−MDM on the other hand, are highly permissive
to HIV-1 infection, and may not readily transfer virus to
macrophages. Should interventions be aimed at the permissive
macrophage subset, or should it be focused on the restrictive macrophage subset that capture and facilitate transfer
of virus to other cells? This highlights the complex role of
macrophages in HIV-1 pathogenesis. Our data suggest that
interventions should aim to block interactions between HIV-1
and macrophages.

adherent MDM were Siglec-1LoCD4−. The non-adherent Siglec1hiCD4+MDM comprised the smaller subset and varied among
the donors. Although both subsets expressed comparable levels
of CD14 and CCR5, only the non-adherent Siglec-1hiCD4+MDM
expressed CD163. Interestingly, in vitro culture of fractionated
adherent Siglec-1LoCD4−MDM gave rise to non-adherent Siglec1hiCD4+MDM, suggesting that Siglec-1LoCD4−MDM may be the
precursors of Siglec-1hiCD4+MDM. This highlights the plasticity
of MDM and is in line with a previous observation that showed
adherent interstitial lung macrophages as the precursors of nonadherent alveolar macrophages (15).
We found that significantly more HIV-1 was captured by the
non-adherent Siglec-1hiCD4+MDM than their adherent Siglec1LoCD4−MDM counterparts. We and others have reported that
Siglec-1 is an attachment molecule for HIV-1 (20, 21). Therefore,
it is probable that the higher expression of HIV-1 associated
cellular receptors on Siglec-1hiCD4+MDM may have resulted
in a propensity for more efficient virus capture. Interestingly,
although more HIV-1 was captured by the non-adherent Siglec1hiCD4+MDM, infection was significantly restricted in these
cells. Indeed, irrespective of donor, HIV-1 infection with BaL,
US-1, or JRFL was consistently lower in the non-adherent Siglec1hiCD4+MDM, than in the adherent Siglec-1LoCD4−MDM.
Our observation that HIV-1 permissiveness was subset
related has been reported in other cell types. In HIV-1-infected
patients, evidence of HIV-1 infection is detected in only a very
small number of monocytes (54). Characterization of monocyte
subsets revealed that CD16+ monocytes were more permissive
to HIV-1 than CD16− monocytes (58, 59), demonstrating that
CD16+ monocytes are the HIV-1 permissive monocyte subset.
In the lungs of HIV-1 infected subjects, HIV-1 preferentially
localized in a subset of small alveolar macrophages (14). Among
CD4+ T cells, CCR4+CCR6− T cells and CXCR3+CCR6+ T cells
are highly permissive to both R5 and X4 HIV-1 viruses, whereas
CXCR3+CCR6− T cells are resistant to both R5 or X4 viruses (60).
Our data highlighted interesting differences between the
non-adherent Siglec-1hiCD4+MDM and the adherent Siglec1LoCD4−MDM in their capacities to transfer HIV-1 to other
MDM. Non-adherent Siglec-1hiCD4+MDM which were more
restrictive to HIV-1 infection transferred virus to adherent
Siglec-1LoCD4−MDM. This suggests that Siglec-1hiCD4+MDM
and Siglec-1LoCD4−MDM may have distinct roles or functions
in the context of HIV-1 infection. The restrictive phenotype of
non-adherent Siglec-1hiCD4+MDM suggests that these cells
primarily capture HIV-1 and could transfer the captured virus to
other cells. In contrast, the permissive phenotype of the adherent
Siglec-1LoCD4−MDM suggests these as the preferential subset
for HIV-1 infection. Indeed, the higher expression of integrins/
adhesion molecules by the non-adherent Siglec-1hiCD4+MDM
(LFA-1, ICAM-1, ICAM-2, ICAM-3, and ICAM-5) further suggest that they probably interact more efficiently with other cells
compared to Siglec-1LoCD4−MDM.
It has been previously demonstrated that differences in HIV-1
permissiveness has been related to the differential expression
of intrinsic anti-HIV-1 cellular factors (61–63). We examined
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